10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 143,530 | 125,297 | 115,842 | 105,821 | 112,218 |
| Cost of Goods | 27,598 | 24,518 | 4,915 | 17,060 | 18,897 |
| Gross Profit | 115,932 | 100,779 | 110,927 | 88,761 | 93,321 |
| Operating Expenses | 132,360 | 117,176 | 122,170 | 99,037 | 503,801 |
| Operating Income | -15,830 | -15,879 | -10,328 | -10,216 | -409,583 |
| Interest Expense | 217 | 219 | 209 | 221 | 317 |
| Other Income | 54 | -550 | 579 | -679 | 1,277 |
| Pre-tax Income | -15,993 | -16,648 | -9,958 | -11,116 | -408,623 |
| Income Tax | 2,456 | 523 | 1,094 | 435 | 6,950 |
| Net Income Continuous | -18,449 | -17,171 | -11,052 | -11,551 | -415,573 |
| Net Income | $-18,449 | $-17,171 | $-11,052 | $-11,551 | $-415,573 |
| EPS Basic Total Ops | -0.17 | -0.15 | -0.10 | -0.11 | -4.09 |
| EPS Basic Continuous Ops | -0.17 | -0.15 | -0.10 | -0.11 | -4.09 |
| EPS Diluted Total Ops | -0.17 | -0.15 | -0.10 | -0.11 | -4.09 |
| EPS Diluted Continuous Ops | -0.17 | -0.15 | -0.10 | -0.11 | -4.09 |
| EBITDA(a) | $-8,506 | $-8,604 | $-3,141 | $-3,748 | $-404,167 |